Topical roflumilast formulation having improved delivery and plasma half-life | Patent Publication Number 20230310397
US 20230310397 A1Publication DateOct 5, 2023
Original AssigneeArcutis Biotherapeutics Inc.
Current AssigneeIplg Llp
Inventor/ApplicantsDavid W. Osborne
Archie W. THURSTON, JR.
David W. OSBORNE
Bhaskar CHAUDHURI
Archie W. THURSTON, JR.
David W. OSBORNE
Bhaskar CHAUDHURI
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.